Altium Capital Management LP Haemonetics Corp Transaction History

Altium Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $3.67 Million - $5.52 Million	-74,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $1.21 Million - $1.48 Million	21,000 Added 39.62%	74,000 $5.28 Million
Q2 2021 Aug 13, 2021	BUY	$51.81 - $118.56 $1.86 Million - $4.26 Million	35,956 Added 210.96%	53,000 $3.53 Million
Q1 2021 May 06, 2021	SELL	$111.01 - $139.48 $1.01 Million - $1.27 Million	-9,100 Reduced 34.81%	17,044 $1.89 Million
Q4 2020 Feb 16, 2021	BUY	$88.75 - $119.95 $2.32 Million - $3.14 Million	26,144 New	26,144 $3.11 Million

337

54.3M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.05B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.